CFO & COO of Heartware International Inc (HTWR, Financial) David Mcintyre sells 1,000 shares of HTWR on 11/16/2009 at an average price of $32.17 a share.
HeartWare International, Inc. along with its subsidiaries is a medical device company focused on developing and commercializing small implantable pumps for the treatment of chronic and end-stage heart failure. Its principle product, the HeartWare Ventricular Assist System, includes a left ventricular assist device, related accessories and surgical tools and is designed to provide circulatory support for patients with advanced heart failure. The company is also developing the Miniaturized Ventricular Assist Device focused on minimally invasive implantation techniques. HeartWare is also developing a portfolio of further miniaturized devices, implantable by progressively less invasive surgery. The Company's corporate headquarters are in Framingham, Massachusetts and its operating and manufacturing activities are based in Miami Lakes, Florida. Heartware International Inc has a market cap of $340.9 million; its shares were traded at around $33.04 with and P/S ratio of 1026.6.
HeartWare International, Inc. along with its subsidiaries is a medical device company focused on developing and commercializing small implantable pumps for the treatment of chronic and end-stage heart failure. Its principle product, the HeartWare Ventricular Assist System, includes a left ventricular assist device, related accessories and surgical tools and is designed to provide circulatory support for patients with advanced heart failure. The company is also developing the Miniaturized Ventricular Assist Device focused on minimally invasive implantation techniques. HeartWare is also developing a portfolio of further miniaturized devices, implantable by progressively less invasive surgery. The Company's corporate headquarters are in Framingham, Massachusetts and its operating and manufacturing activities are based in Miami Lakes, Florida. Heartware International Inc has a market cap of $340.9 million; its shares were traded at around $33.04 with and P/S ratio of 1026.6.
Insiders' Positions with HTWR
- Sell:: CFO & COO David Mcintyre sold 1,076 shares of HTWR stock on 07/17/2009 at the average price of 22.59, the price of the stock has increased by 46.26% since
Insiders' Positions with HTWR
- Buy:: 10% Owner Muneer A Satter bought 3 shares of HTWR stock on 08/13/2009 at the average price of 23.79, the price of the stock has increased by 38.88% since
- Sell:: Chief Scientifc Officer Jeffrey Larose sold 17,000 shares of HTWR stock on 09/15/2009 at the average price of 28, the price of the stock has increased by 18% since
- Sell:: Chief Scientifc Officer Jeffrey Larose sold 5,513 shares of HTWR stock on 09/02/2009 at the average price of 25.84, the price of the stock has increased by 27.86% since
- Sell:: VP, Finance Lauren Farrell sold 307 shares of HTWR stock on 07/17/2009 at the average price of 22.59, the price of the stock has increased by 46.26% since
- Sell:: President & Chief Exec Officer Douglas Evan Godshall sold 3,375 shares of HTWR stock on 07/17/2009 at the average price of 22.59, the price of the stock has increased by 46.26% since
